Select a Region North America

Insights

Insights From Our Experts

Articles

Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact

In the dynamic realm of pharmaceutical marketing, sales representatives and television commercials remain go-to strategies, skillfully weaving narratives that assure patients of a brand’s therapeutic benefits and persuade providers to alter prescribing habits. Despite their effectiveness,…

There’s a New Way to Omnichannel: Orchestrating Experience to Drive Sales, Savings and Satisfaction

The current state of omnichannel initiatives in the life sciences industry has often been characterized by incremental effectiveness, high costs, complexity, siloed approaches and slow progress. This is not a condemnation of the omnichannel concept, but…

Orchestrating Experiences That Simultaneously Drive Brand Impact and Customer Delight

The evolving landscape of HCP and patient engagement in the pharmaceutical industry necessitates omnichannel solutions that successfully cover multiple touchpoints such as field, web, email, conferences and more. Not only are brands expected to cover these…

Continuous Manufacturing of Pharmaceutical Products: The New Norm

The life sciences sector is changing for the new pharma generation with the introduction of many forms of updated technology and solutions. Continuous manufacturing (CM) is a perfect example. CM is a method for manufacturing pharmaceutical…

Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada

Discover the groundbreaking strategy that could redefine pharmaceutical launches and propel your product’s success across North America. In the realm of pharmaceutical launches, a paradigm shift is underway, challenging the conventional sequential approach and calling for…

Health Disparity Solutions Build Healthier Communities and a More Equitable Medical Landscape

Achieving equity within healthcare is a harrowing but imperative goal for the industry. Lack of safe housing and healthy food, low income, ethnicity, race, rural living and other social determinants of health (SDOH) can have a…

Digital Guide to Commercializing Complex Therapeutics

Pharmaceutical manufacturers specializing in Rare Disease, Oncology, Personalized Cancer Immunotherapy, and Cell and Gene therapies encounter a range of complex challenges, including advancements in medicine and technology, changing patient and provider needs, market access, regulatory pathways,…

FRM Satisfaction Survey POV
Elevating Field Reimbursement Manager Performance through Insights & Comparative Data

“Elevating Field Reimbursement Managers’ Performance through Customer-based Insights and Comparative Data,” authored by David Frey, Principal, Specialty Consulting, EVERSANA and Lee Ann Steadman, Senior Vice President, Specialty Consulting, EVERSANA explores the evolving role of Field Reimbursement…

Missed Connection or Meant to Be?

EVERSANA is raising the questions the industry is thinking but is too afraid to ask aloud: Has omnichannel lived up to its promise of the “right message at the right time” to drive meaningful results that…

Invisible Orchestration: How Behind-the-Scenes Collaboration of Patient Services and Field Deployment Teams Delivers a Seamless Front-of-House Brand Experience

Providing services to patients in a digital world requires a delicate balance of blending high-tech and high-touch solutions. A majority of patients want the option to guide their own treatment journeys with ease and on their…